{
    "Trade/Device Name(s)": [
        "Ultra HDL"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K051962",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021316"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBS"
    ],
    "Summary Letter Date": "August 25, 2005",
    "Summary Letter Received Date": "July 19, 2005",
    "Submission Date": "July 12, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "High-density lipoprotein cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AEROSET System",
        "ARCHITECT c8000 System",
        "Hitachi 717 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzymatic assay",
        "Colorimetric detection"
    ],
    "Methodologies": [
        "Enzyme reaction",
        "Chromagenic coupling"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Ultra HDL homogeneous enzymatic assay for quantitative measurement of HDL cholesterol in human serum or plasma",
    "Indications for Use Summary": "Used for quantitation of high-density lipoprotein cholesterol levels in human serum or plasma; low HDL measurements aid in diagnosis and treatment of coronary artery disease",
    "fda_folder": "Clinical Chemistry"
}